The use of allopurinol in prophylaxis against contrast-induced nephropathy in patients undergoing percutaneous coronary intervention

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Risk stratification in percutaneous coronary intervention (1) Prevention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by